Answers are grounded in this paper and cite their sources.
We prospectively analyzed three types of ureteral stents to determine the effects of diameter and composition on a patient's symptoms. Twenty stents were placed consecutively in each of the three study groups for the treatment of ureteral obstruction, prior to SWL, or following ureteroscopy: Group I = 6F Percuflex stent, Group II = 6F HydroPlus stent, and Group III = 4.8F HydroPlus stent. All stents were removed in clinic 7 to 10 days after placement. At this time, a confidential questionnaire was completed by the patient addressing the symptoms associated with the indwelling catheter. The 6F hydrogel-coated stents were somewhat easier to insert, especially in high-grade obstructions. Occasional difficulty in seeing the 4.8F stent during fluoroscopy was noted. No statistically significant difference in any of the irritative voiding symptoms-dysuria (P = 0.7998), urgency (P = 0.0928), frequency (P = 0.2646), nocturia (P = 0.2855), hematuria (P = 0.9417), pain (P = 0.4524), or incontinence (P = 0.4524)-was demonstrated. Differences in stent diameter and composition do not appear to affect symptoms. We prefer the hydrogel-coated 6F stent, as it offers advantages in ease of placement and radiographic visibility without increased symptoms.
No takes yet. Share an insight, caveat, or question.
Candela et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: